From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Project cooperationUpdated on 23 May 2026

Green energy products in a closed loop.

Prezes Zarządu i dyrektor projektu at MŚP

Warszawa, Poland

About

According to the Union's guidelines and the strategy of international cooperation in the field of scientific research and innovation, "Horizon Europe is open to the participation of scientists and company. Along with the intensification of scientific research and innovation in partner countries, access to the best scientists and research centers in the world is of key importance for Europe. In this way, not only sources of new ideas and expert knowledge are provided - it is no less important to ensure the ability of European scientists to cooperate with the best in a given field around the world. Green current from small proven turbines for the entire 24 hours. It is important to develop and bring to market affordable, cost-effective and resource-efficient technology solutions to sustainably decarbonize the energy system, secure energy supplies and complete the internal energy market. Research activities in this area will include: Photovoltaics, Concentrated Solar Energy, Wind Energy, Ocean Energy, Hydropower, Geothermal Energy, Renewable Heating and Cooling, Energy Storage, Biofuels and Alternative Fuels, Carbon Capture and Storage. All products and related components will require the involvement of new entities, on the one hand to use and use new technologies, and on the other hand to initiate and drive changes. According to the Union's guidelines and the strategy of international cooperation in the field of scientific research and innovation, "Horizon Europe is open to the participation of scientists and company. Sustainable urban development is a key challenge, requiring new, efficient and user-friendly technologies and services, especially in the areas of energy. However, public transport and these solutions require an integrated approach, both in terms of research and development of advanced technological solutions, as well as implementation. Focus on technologies will result in commercial-scale solutions with high market potential

Stage

  • Execution

Topic

  • IHI Topic 1: IHI European healthcare incubator network

Type

  • Partner offering expertise and is looking for a consortium
  • Consortium looking for partners

Organisation

MŚP

Company (SME)

Warszawa, Poland

Similar opportunities

  • Project cooperation

    Dbamy o Zdrowie i biznes

    • Planning
    • Consortium looking for partners
    • IHI Topic 1: IHI European healthcare incubator network
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)
    • HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    • IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
    • HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

    Krzysztof Dionizy Pułaski

    Prezes i dyrektor projektu at MŚP

    Warszawa, Poland

  • Project cooperation

    Digital Health & AI/ML SME | Real-World Data, Interoperability & Clinical AI Expertise Seeking CARMEN2026 Looking for a consortium to join with Widening Option

    • IHI Topic 1: IHI European healthcare incubator network
    • Partner offering expertise and is looking for a consortium
    • IHI Topic 3: Decode the immuno-science of age-related mediated diseases
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)
    • HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    • IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)
    • HORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)
    • HORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
    • HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
    • HORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
    • HORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

    Elifnaz Unay Kılıç

    EU Technology & Funds Manager at TİGA

    Ankara, Türkiye

  • Expertise

    Expertise on biotech and deeptech problems

    Christos Kotakis

    CEO, Founder at citrusgenetics

    Gastouni, Greece